Commodore Capital LP
- SEC CIK
- 0001831942
- Latest filing
- Aug 14, 2026
SABS holding history
SAB Biotherapeutics, Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SABS overviewAll 13F holders of SABSFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,870,000
- Value
- $11.2M
- % of portfolio
- 0.7%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,870,000 | $11.2M | 0.7% | −1,531,500−34.8% | Reduced | Holders |
| Q1 2026 | 4,401,500 | $16.9M | 1.0% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4,401,500 | $16.5M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 4,401,500 | $8.85M | 0.4% | +4,401,500 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −183,174−100.0% | Sold out | Holders |
| Q1 2024 | 183,174 | $831.6K | 0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q4 2023 | 1,831,746 | $1.26M | 0.1% | +1,831,746 | New | Holders |